Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that scalp health is influenced by complex factors affecting sebaceous glands, including hormones, aging, and various substances.

Hair from balding and non-balding areas regrows similarly on mice.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

A hair transplant using hair from the back of the head and pubic area was successful in creating a feminine hairline for a male-to-female transgender person.

DHT may reduce inflammation caused by certain bacteria in skin cells.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

Higher caspase-1 levels found in balding scalps; reducing it may help treat hair loss.

Researchers created five new human scalp cell lines that could be useful for hair growth and loss research.

Intramuscular injections improved hair density more than intradermal injections for treating hair loss.

Iron supplements may reverse premature hair graying caused by iron deficiency.

Hair loss requires customized treatments based on its various causes and types.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

The document concludes that new treatments for hair loss may involve a combination of cosmetics, clinical methods, and genetic approaches.

Microneedle therapy combined with serum effectively increases hair count in people with hair loss, with no side effects.

Men with androgenetic alopecia have oilier and less hydrated scalps, especially in sensitive areas.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

The cross beam laser is a useful tool for safely measuring scalp stretchiness to improve hair transplant results.

Botulinum toxin may help treat hair loss by relaxing scalp muscles, improving oxygen and blood flow.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Mice with human gene experienced hair loss when treated with DHT.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Finasteride potentially treats hair loss by reducing DHT production.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Rat skin takes up and processes testosterone differently than other organs, with testosterone being more important for the skin than its metabolite 5α-DHT.